text_1: Toll-like receptor (TLR) signaling is involved in the pathogenesis of human MDS.
text_2: Thus, alarmins and founder gene mutations in MDSs license a common redox-sensitive inflammasome circuit, which suggests new avenues for therapeutic intervention.